Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
Thu, September 2, 2010
Wed, September 1, 2010
Tue, August 31, 2010
Mon, August 30, 2010
Sun, August 29, 2010
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ] - Market Wire
?????????????????????
Thu, August 26, 2010
Wed, August 25, 2010

Kendall Law Group Investigates ZymoGenetics, Inc. Acquisition for Shareholders


//health-fitness.news-articles.net/content/2010/ .. mogenetics-inc-acquisition-for-shareholders.html
Published in Health and Fitness on Wednesday, September 8th 2010 at 6:42 GMT by Market Wire   Print publication without navigation


DALLAS--([ BUSINESS WIRE ])--[ Kendall Law Group ], a national securities firm led by a former federal judge with attorneys that include a former U.S. Attorney, is investigating ZymoGenetics, Inc. (NASDAQ: ZGEN) for shareholders in connection with the proposed acquisition by the Bristol-Myers Squibb Company. The national securities firma™s investigation seeks to determine whether ZymoGenetics and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a ZymoGenetics shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at [ skendall@kendalllawgroup.com ].

On September 7, 2010 the companies announced that the companies have entered into a definitive merger agreement under which ZymoGenetics would be acquired by Bristol-Myers Squibb in a transaction valued at approximately $735 million net of cash acquired. Under the terms of the agreement, ZymoGenetics stockholders will receive $9.75 in cash for each share of ZymoGenetics/ZGEN common stock held. The firma™s investigation seeks to discover whether the transaction properly values the company.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.


Publication Contributing Sources